findmyKOL
Clinical trialNCT02792114Active, not recruitingPhase 1Interventional

T-Cell Therapy for Advanced Breast Cancer

SponsorMemorial Sloan Kettering Cancer CenterEnrollment186Breast CancerMetastatic HER2-negative Breast
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Memorial Sloan Kettering Cancer Center (consent and Follow-Up Only)

    Basking Ridge, New Jersey, United States

  • Memorial Sloan Kettering Monmouth (consent and Follow-Up Only)

    Middletown, New Jersey, United States

  • Memorial Sloan Kettering Bergen (consent and Follow-Up Only)

    Montvale, New Jersey, United States

  • Memorial Sloan Kettering Cancer Center at Commack (consent and Follow-Up Only)

    Commack, New York, United States

  • Memorial Sloan Kettering Westchester (consent and Follow-Up Only)

    East White Plains, New York, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Memorial Sloan Kettering Nassau (consent and Follow-Up Only)

    Uniondale, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2016
Primary completion
30 Jun 2026
Completion
30 Jun 2026
Last update posted
17 Jul 2025
Registered enrollment
186
Registry id
NCT02792114

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.